國家衛生研究院 NHRI:Item 3990099045/14250
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12189/12972 (94%)
造訪人次 : 955421      線上人數 : 713
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/14250


    題名: Compassionate treatment of brainstem tumors with boron neutron capture therapy: A case series
    作者: Chen, YW;Lee, YY;Lin, CF;Huang, TY;Ke, SH;Mu, PF;Pan, PS;Chen, JK;Lan, TL;Hsu, PC;Liang, ML;Chen, HH;Chang, FC;Wu, CC;Lin, SC;Lee, JC;Chen, SK;Liu, HM;Peir, JJ;Tsai, HY;Lin, KH;Peng, NJ;Chen, KH;Wu, YH;Kang, YM;Yang, WC;Liou, SC;Huang, WH;Tanaka, H;Wong, TT;Chao, Y;Chou, FI
    貢獻者: Institute of Biomedical Engineering and Nanomedicine
    摘要: Brainstem tumors are heterogenous and cancerous glioma tumors arising from the midbrain, pons, and the medulla that are relatively common in children, accounting for 10% to 20% of all pediatric brain tumors. However, the prognosis of aggressive brainstem gliomas remains extremely poor despite aggressive treatment with chemotherapy and radiotherapy. That means there are many life-threatening patients who have exhausted all available treatment options and are beginning to face end-of-life stage. Therefore, the unique properties of highly selective heavy particle irradiation with boron neutron capture therapy (BNCT) may be well suited to prolong the lives of patients with end-stage brainstem gliomas. Herein, we report a case series of life-threatening patients with end-stage brainstem glioma who eligible for Emergency and Compassionate Use, in whom we performed a scheduled two fractions of salvage BNCT strategy with low treatment dosage each time. No patients experienced acute or late adverse events related to BNCT. There were 3 patients who relapsed after two fractionated BNCT treatment, characterized by younger age, lower T/N ratio, and receiving lower treatment dose. Therefore, two fractionated low-dose BNCT may be a promising treatment for end-stage brainstem tumors. For younger patients with low T/N ratios, more fractionated low-dose BNCT should be considered.
    日期: 2022-04-10
    關聯: Life-Basel. 2022 Apr 10;12(4):Article number 566.
    Link to: http://dx.doi.org/10.3390/life12040566
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=2075-1729&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000785658700001
    Cited Times(Scopus): https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85129084036
    顯示於類別:[陳仁焜] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    ISI000785658700001.pdf1992KbAdobe PDF152檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋